Roslyn M. “Roz” Meyer, PhD, and her husband, Jerome H. “Jerry” Meyer, MD, will never forget the torment they felt when Roz was diagnosed with stage IV melanoma in 2005. “The worst part was not knowing what to do or where to turn,” said Jerry. “It was anguish.”
But with the help of Yale Cancer Center and, specifically, Mario Sznol, MD, Professor of Medicine (Medical Oncology), Roz was able to join an experimental program at the National Institutes of Health (NIH) in Bethesda, MD, run by Steven A. Rosenberg, MD, PhD, who pioneered the development of effective immunotherapies and gene therapies for patients with advanced cancer. Eighteen years later, she remains healthy.
“It’s in the realm of the miraculous,” commented Jerry.
Roz and Jerry made the decision to apply for a clinical trial at the National Cancer Institute in Bethesda, Maryland, since the standard treatments at the time did not work. They were lucky that Roz met the eligibility requirements for the trial, and that her outcome was successful. But they always wished that patients could have access to those kinds of treatments close to home. Their original philanthropy to Yale Cancer Center was to create such a program at Yale, including a recent $500,000 donation to the Meyer Fund for Melanoma Research, which was established through a foundational multi-million dollar gift.
“Jerry and I really believe in trying to make cancer treatment available to as many people as possible, as close to home as possible,” Roz said. “One of the things we love about Eric Winer (YCC Director) is that he’s focusing on making sure everyone has equal access to topnotch healthcare.”
When Roz was diagnosed, there were no effective treatments. “Surgery helped for a while but then it would pop back up, and vaccines in general did not work,” she said. But after they returned from the NIH and her health improved, the couple focused their generosity—a constant in their lives—on healthcare.